Literature DB >> 16155734

Androgenic correlates of genetic variation in the gene encoding 5alpha-reductase type 1.

Justine A Ellis1, Sianna Panagiotopoulos2, Aysel Akdeniz2, George Jerums2, Stephen B Harrap3.   

Abstract

Androgens determine male secondary sexual characteristics and influence a variety of metabolic pathways. Circulating levels of androgens are highly heritable; however, the genes involved are largely unknown. The 5alpha-reductase enzymes types 1 and 2 responsible for converting testosterone to the more potent androgen dihydrotestosterone are encoded by the SRD5A1 and SRD5A2 genes, respectively. We performed indirect genetic association studies of SRD5A1 and SRD5A2 and the dihydrotestosterone/testosterone ratio that reflects the activity of 5alpha-reductase in 57 males with type 2 diabetes. We found evidence of significant association between a single nucleotide polymorphism in SRD5A1 and the dihydrotestosterone/testosterone ratio (median 0.10, interquartile range 0.08 vs. median 0.06, interquartile range 0.04, P = 0.009). The polymorphism was not associated with any diabetic phenotypes. These results suggest that functional genetic variants might exist in or around SRD5A1 that affect the activity of the 5alpha-reductase enzyme type 1 and influence androgen levels.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16155734     DOI: 10.1007/s10038-005-0289-x

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  13 in total

1.  A critical evaluation of simple methods for the estimation of free testosterone in serum.

Authors:  A Vermeulen; L Verdonck; J M Kaufman
Journal:  J Clin Endocrinol Metab       Date:  1999-10       Impact factor: 5.958

2.  Quantitating genetic and nongenetic factors that determine plasma sex steroid variation in normal male twins.

Authors:  A W Meikle; D T Bishop; J D Stringham; D W West
Journal:  Metabolism       Date:  1986-12       Impact factor: 8.694

3.  Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression.

Authors:  A E Thigpen; R I Silver; J M Guileyardo; M L Casey; J D McConnell; D W Russell
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

Review 4.  Androgens and coronary artery disease.

Authors:  Fredrick C W Wu; Arnold von Eckardstein
Journal:  Endocr Rev       Date:  2003-04       Impact factor: 19.871

Review 5.  Sex steroids and insulin resistance.

Authors:  Callum Livingstone; Mary Collison
Journal:  Clin Sci (Lond)       Date:  2002-02       Impact factor: 6.124

6.  Genetic analysis of male pattern baldness and the 5alpha-reductase genes.

Authors:  J A Ellis; M Stebbing; S B Harrap
Journal:  J Invest Dermatol       Date:  1998-06       Impact factor: 8.551

7.  Quantitating genetic and nongenetic factors influencing androgen production and clearance rates in men.

Authors:  A W Meikle; J D Stringham; D T Bishop; D W West
Journal:  J Clin Endocrinol Metab       Date:  1988-07       Impact factor: 5.958

Review 8.  Androgen receptor and mechanism of androgen action.

Authors:  O A Jänne; J J Palvimo; P Kallio; M Mehto
Journal:  Ann Med       Date:  1993-02       Impact factor: 4.709

Review 9.  Androgens and bone.

Authors:  Dirk Vanderschueren; Liesbeth Vandenput; Steven Boonen; Marie K Lindberg; Roger Bouillon; Claes Ohlsson
Journal:  Endocr Rev       Date:  2004-06       Impact factor: 19.871

10.  Nonalbuminuric renal insufficiency in type 2 diabetes.

Authors:  Richard J MacIsaac; Con Tsalamandris; Sianna Panagiotopoulos; Trudy J Smith; Karen J McNeil; George Jerums
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

View more
  9 in total

1.  Ethanol withdrawal-induced dysregulation of neurosteroid levels in plasma, cortex, and hippocampus in genetic animal models of high and low withdrawal.

Authors:  Jeremiah P Jensen; Michelle A Nipper; Melinda L Helms; Matthew M Ford; John C Crabbe; David J Rossi; Deborah A Finn
Journal:  Psychopharmacology (Berl)       Date:  2017-06-29       Impact factor: 4.530

2.  A population-based study of polymorphisms in genes related to sex hormones and abdominal aortic aneurysm.

Authors:  Jonathan Golledge; Erik Biros; Nicole Warrington; Gregory T Jones; Matthew Cooper; Andre M van Rij; Lyle J Palmer; Paul E Norman
Journal:  Eur J Hum Genet       Date:  2010-12-01       Impact factor: 4.246

3.  Variation in genes encoding the neuroactive steroid synthetic enzymes 5α-reductase type 1 and 3α-reductase type 2 is associated with alcohol dependence.

Authors:  Verica Milivojevic; Henry R Kranzler; Joel Gelernter; Linda Burian; Jonathan Covault
Journal:  Alcohol Clin Exp Res       Date:  2011-02-15       Impact factor: 3.455

4.  Null mutation of 5α-reductase type I gene alters ethanol consumption patterns in a sex-dependent manner.

Authors:  Matthew M Ford; Jeffrey D Nickel; Moriah N Kaufman; Deborah A Finn
Journal:  Behav Genet       Date:  2014-11-23       Impact factor: 2.805

5.  Sex dependent influence of a functional polymorphism in steroid 5-α-reductase type 2 (SRD5A2) on post-traumatic stress symptoms.

Authors:  Charles F Gillespie; Lynn M Almli; Alicia K Smith; Bekh Bradley; Kimberly Kerley; Daniel F Crain; Kristina B Mercer; Tamara Weiss; Justine Phifer; Yilang Tang; Joseph F Cubells; Elisabeth B Binder; Karen N Conneely; Kerry J Ressler
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2013-03-15       Impact factor: 3.568

6.  Polymorphisms of steroid 5-alpha-reductase type I (SRD5A1) gene are associated to peripheral arterial disease.

Authors:  S S Signorelli; V Barresi; N Musso; M Anzaldi; E Croce; V Fiore; D F Condorelli
Journal:  J Endocrinol Invest       Date:  2008-12       Impact factor: 4.256

7.  Analysis of the B cell receptor repertoire in six immune-mediated diseases.

Authors:  R J M Bashford-Rogers; L Bergamaschi; E F McKinney; D C Pombal; F Mescia; J C Lee; D C Thomas; S M Flint; P Kellam; D R W Jayne; P A Lyons; K G C Smith
Journal:  Nature       Date:  2019-09-25       Impact factor: 49.962

8.  Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13).

Authors:  Amy B Hart; Barbara E Engelhardt; Margaret C Wardle; Greta Sokoloff; Matthew Stephens; Harriet de Wit; Abraham A Palmer
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

9.  "Cold" X5 Hairlaser™ used to treat male androgenic alopecia and hair growth: an uncontrolled pilot study.

Authors:  Kenneth Blum; David Han; Margaret A Madigan; Raquel Lohmann; Eric R Braverman
Journal:  BMC Res Notes       Date:  2014-02-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.